As the first Canadian union to actively provide comprehensive medical cannabis coverage, eligible members from LiUNA Local 1258 in Manitoba are now added to the program
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) has added eligible members of Labourers’ International Union of North America (“LiUNA”) Local 1258, headquartered in Manitoba, to its full-service medical cannabis program. Eligible members and their dependents can now access Starseed products via their benefits provider.
LiUNA is the largest construction union in Canada which provides benefit coverage to over 300,000 people, including members and their dependents. With the addition of LiUNA Local 1258, it becomes the sixth local to be onboarded onto Starseed’s unique and ground-breaking medical cannabis program, joining Ontario chapters with locals in Toronto, Hamilton, Windsor and London currently enrolled in the program.
“We congratulate LiUNA and its newest eligible members from Local 1258 in Manitoba for continuing to make history in Canada and around the world as a leader in actively providing important medical cannabis coverage as an alternate therapy and way to combat the opioid crisis,” said George Scorsis, Executive Chairman and Interim CEO of WeedMD. “Starseed has been providing cannabis education and a full service medical platform rooted in medical-grade cannabis products to LiUNA members since 2018, and we welcome Local 1258 to our unique program.”
“For generations, the LiUNA 1258 multi-employer health and welfare benefit trust plan has been providing affordable and accessible quality coverage to its members including retirees and their dependents and we’re pleased to be expanding that offering to include medical cannabis as a therapeutic alternative,” said Victor DaSilva, Business Manager of LiUNA Local 1258. “With Starseed Medicinal, our eligible members now have access to some of the most trusted products in Canada to suit their individual healthcare needs as we look to foster access to medical cannabis education and ease of access.”
Starseed’s medical program is built around a system that brings together clinical practitioners who specialize in chronic pain, opioid cessation, and diabetes. Its medical marketplace is built around a revolutionary Canadian virtual pharmacy system that takes online orders and has the ability to intuitively complete the claims management process seamlessly with insurance carriers.
About WeedMD Inc.
WeedMD Inc. is the publicly traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, ON as well as a fully-licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday Cannabis are sold.
Follow WeedMD and its brands on LinkedIn
For further information, please contact:
For Investor Enquiries:
KCSA Strategic Communications
For Media Enquiries:
Director of Communications, Public Relations & Marketing
VP, Communications & Corporate Affairs
To learn more, visit us at www.weedmd.com
Forward Looking Information This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE